almagate has been researched along with von Hippel-Lindau Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chew, EY; Cusick, M; Dahr, SS; Ferris, FL; Linehan, WM; Rodriguez-Coleman, H; Srivastava, SK; Thompson, DJ | 1 |
1 trial(s) available for almagate and von Hippel-Lindau Disease
Article | Year |
---|---|
Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina.
Topics: Adult; Aptamers, Nucleotide; Female; Fluorescein Angiography; Hemangioma, Capillary; Humans; Injections; Male; Middle Aged; Pilot Projects; Prospective Studies; Retinal Neoplasms; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body; von Hippel-Lindau Disease | 2007 |